Cell Wall Synthesis Inhibitors Flashcards
Formation of cell wall predecessor
NAM NAG complex - GAG
1. NAG + PEP using EPT Enolpyruvate transferase
2. NAM-NAG complex-GAG
Peptide chains ⛓:
1. L-alanine to D-form by alanine racemase
2. To alanine library chain by alanine ligase
3. Glycine added to it to form a T-shaped peptide
Cell wall formation from cell wall precursor
- Both the precursors joint in cytoplasm
- It is transported outside the cell membrane by lipid transporter (bactoprenol)
- It is polymerized by transpeptidase
Drugs acting on cell wall synthesis
- Fosfomycin and fosmidomycin 🅱️ EPT
- Cycloserine: 🅱️ alanine racemase, alanine ligase
- Bacitracin: 🅱️ lipids transporter
- Glycopeptides: vancomycin
🅱️ D-alanine from forming cross-links - β-lactams: 🅱️ transpeptidase
Penicillins, cephalosporins, monobactams, carbapenems
Fosfomycin and fosfodomycin
mechanism and pharmacokinetics
Analogues of PEP ➡️ competitive 🅱️ of EPT
Pharmacokinetics:
• excreted unchanged in urine ➡️ UTI 3gm single dose
• safe in 🤰
Fosfomycin and fosfodomycin
spectrum
Limited spectrum
G-6-P transporter required for transportation into cell ➡️ only gram ➖ve bacteria
Eg., E. coli, klebsiella, serratia
Cycloserine
• D-alanine analogue ➡️ 🅱️ alanine racemase, ligase ➡️ cell wall synthesis 🅱️
• Gram ➖ve bacteria
• 2nd line drug for TB
• S/E: neuropsychiatric
Seizure, psychosis, peripheral neuropathy
Bacitracin
🅱️ lipids transporter ➡️ cell wall unit transport 🅱️
S/E:
nephrotoxic and bone marrow suppression ➡️ no systemic use
Topical:
• skin infections
• staph nasal carriers (MRSA)
DoC topical mupirocin
Local: GIT
• pseudomembranous enterocolitis
• VRE (vancomycin resistant enterococcus)
Glycopeptides
effects of its size
Large in size ➡️ 🔽 oral absorption
Spectrum:
Gram ➕ve bacteria
In gram -ve bacteria, porins allow only small size molecules and water soluble particles to pas
Vancomycin
IV route: DoC
1. MRSA
2. Enterococcus faecium
3. Ampicillin resistant enterococcus faecalis
Oral route: DoC
Pseudomrmbranous enterocolitis
• if not responding: fidaxomycin, rifaximin
S/E:
1. 🔼 release of histamine: red neck/man syndrome
2. Nephrotoxic
3. Ototoxic
Recent advances for prophylaxis of pseudomembranous enterocolitis
- Bezlotoxumab
Anticlostridium difficile toxin-B antibody - Actozumab:
Anticlostridium difficile toxin-A antibody
Other glycopeptide drugs
- Teicoplanin
- Dalbavancin: long acting
- Telavancin and Oritavancin:
Disrupts cell membrane ➡️ 🔼bactericidal
Use: only for SSTI by MRSA
Narrow spectrum penicillins
Penicillin-G • lipid soluble • active day 1. G ➕ve 2. Some G ➖ve bacteria (meningococcus) Structure: R group present
Broad spectrum
• Amidase enzyme ➡️ breaks side chain R
• functional group FG added in place of side chain R
➡️ ionised and water soluble
➡️ active against G ➖ve also
Classification of broad spectrum penicillins
1. Amino (+ve): orally • amoxicillin, ampicillin 2. Carboxy (-ve): parenteral • carbenicillin, ticaricillin 3. Ureido (+ve, -ve): parenteral Max active against G➖ve organism Piperacillin, Azlocillin, Mazlocillin The last two groups are active against pseudomonas
Amoxicillin
uses
- Diverticulitis
- Cellulitis
- Ludwig’s angina
- Vincent’s angina
- UTI (safe in 🤰)
Ampicillin
uses
DoC for:
- Meningitis by listeria
- H influenza: pneumonia, otitis
- Enterococcus faecalis
- Shigella infections
Uses of ureidopenicillin like piperacillin, mezlocillin
Active against klebsiella and enterococcus
Penicillin G
IV route (aqueous) (IM route ➡️ injection site reaction) Pharmacokinetics: 1. Poor oral absorption: Acid labile unlike acid stable P. V 2. Rapid tubular secretions: P-gp pumps ➡️ Very short acting (long acting can be made)
Long acting penicillin
- P-gp
Probenecid penicillin G
IM route (not IV, toxicity)
Measured in IU, 1mg = 1600 IU - 🔼 H2O solubility:
Given IM:
• procaine penicillin-G: no pain at injection site (local anesthetic)
• benzathine penicillin-G: longest acting (28 days)
DoC: prophylaxis of rheumatic fever (monthly)
Penicillin uses
- Syphilis
- Streptococcus infection
- Gas gangrene
- Yaws
- Leptospirosis
- Rat bite fever
Benzathine penicillin G
2.4 million IU once
• 1° syphilis
• 2° syphilis
S/E: Jarisch Herxheimer reaction (hypersensitivity reaction)
🤒, arthralgia, myalgia, worsening of cutaneous lesion
• Early latent syphilis
Benzathine penicillin G
2.4 million IU 3 doses once/week
- Tertiary syphilis (without CNS involvement)
- CNS involvement
- Late latent
Neurosyphilis
DoC
Aqueous penicillin G
18-24 million IU
Continuous IV infusion (10-14 days)
Mechanism of resistance of penicillin in gram ➖ve bacteria
- Decreased porin production
Eg., pseudomonas - Drug efflux
Eg., pseudomonas, E. coli, gonococcus